BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 10949780)

  • 1. Prognostic factors for hematologic cancers.
    Misra RR; Pinsky PF; Srivastava S
    Hematol Oncol Clin North Am; 2000 Aug; 14(4):907-24, ix-x. PubMed ID: 10949780
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trends in the survival of patients diagnosed with malignant neoplasms of lymphoid, haematopoietic, and related tissue in the Nordic countries 1964-2003 followed up to the end of 2006.
    Storm HH; Klint A; Tryggvadóttir L; Gislum M; Engholm G; Bray F; Hakulinen T
    Acta Oncol; 2010 Jun; 49(5):694-712. PubMed ID: 20491526
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Risk of cancer and malignant transformation in hematology practice].
    Várkonyi J
    Orv Hetil; 2002 Oct; 143(43):2435-8. PubMed ID: 12455145
    [TBL] [Abstract][Full Text] [Related]  

  • 4. B-cell maturation antigen expression across hematologic cancers: a systematic literature review.
    Dogan A; Siegel D; Tran N; Fu A; Fowler J; Belani R; Landgren O
    Blood Cancer J; 2020 Jun; 10(6):73. PubMed ID: 32606424
    [TBL] [Abstract][Full Text] [Related]  

  • 5. No evidence for anticipation in lymphoproliferative tumors in population-based samples.
    Daugherty SE; Pfeiffer RM; Mellemkjaer L; Hemminki K; Goldin LR
    Cancer Epidemiol Biomarkers Prev; 2005 May; 14(5):1245-50. PubMed ID: 15894680
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Family history of hematopoietic malignancy and risk of lymphoma.
    Chang ET; Smedby KE; Hjalgrim H; Porwit-MacDonald A; Roos G; Glimelius B; Adami HO
    J Natl Cancer Inst; 2005 Oct; 97(19):1466-74. PubMed ID: 16204696
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Second cancers in hematologic malignancies (epidemiologic observations from a 20-year period)].
    Jakó J; Szerafin L; Nagy P
    Orv Hetil; 2005 Mar; 146(10):461-9. PubMed ID: 15835344
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk of non-Hodgkin's lymphoma and family history of lymphatic, hematologic, and other cancers.
    Chatterjee N; Hartge P; Cerhan JR; Cozen W; Davis S; Ishibe N; Colt J; Goldin L; Severson RK
    Cancer Epidemiol Biomarkers Prev; 2004 Sep; 13(9):1415-21. PubMed ID: 15342441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cellular and molecular biology of malignant lymphoma].
    Tesch H; Stein H; Diehl V
    Internist (Berl); 1993 Feb; 34(2):89-96. PubMed ID: 8454437
    [No Abstract]   [Full Text] [Related]  

  • 10. Evaluation of Patients and Families With Concern for Predispositions to Hematologic Malignancies Within the Hereditary Hematologic Malignancy Clinic (HHMC).
    DiNardo CD; Bannon SA; Routbort M; Franklin A; Mork M; Armanios M; Mace EM; Orange JS; Jeff-Eke M; Churpek JE; Takahashi K; Jorgensen JL; Garcia-Manero G; Kornblau S; Bertuch A; Cheung H; Bhalla K; Futreal A; Godley LA; Patel KP
    Clin Lymphoma Myeloma Leuk; 2016 Jul; 16(7):417-428.e2. PubMed ID: 27210295
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Premature Mortality Due to Hodgkin Lymphoma, Non-Hodgkin Lymphoma, Multiple Myeloma, and Leukemia in Canada: A Nationwide Analysis From 1980 to 2015.
    Pham TM; Shen-Tu G; Nguyen KH; Lu S; Dover DC; Duggan P; Shack L; Cheung WY
    Am J Epidemiol; 2021 Jan; 190(1):59-75. PubMed ID: 32706884
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trends in 5- and 10-year survival after diagnosis with childhood hematologic malignancies in the United States, 1990-2004.
    Pulte D; Gondos A; Brenner H
    J Natl Cancer Inst; 2008 Sep; 100(18):1301-9. PubMed ID: 18780868
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic relationships in familial leukemia and lymphoma.
    Rigby PG; Pratt PT; Rosenlof RC; Lemon HM
    Arch Intern Med; 1968 Jan; 121(1):67-70. PubMed ID: 4864725
    [No Abstract]   [Full Text] [Related]  

  • 14. Genetic factors in leukemia and lymphoma.
    Ponz de Leon M
    Recent Results Cancer Res; 1994; 136():287-305. PubMed ID: 7863101
    [No Abstract]   [Full Text] [Related]  

  • 15. Progress in the curative treatment of childhood hematologic malignancies.
    Wayne AS; Reaman GH; Helman LJ
    J Natl Cancer Inst; 2008 Sep; 100(18):1271-3. PubMed ID: 18780861
    [No Abstract]   [Full Text] [Related]  

  • 16. Survival of Danish cancer patients 1943-1987. Lymphatic and haematopoietic tissues.
    Strom HH; Clemmensen IH
    APMIS Suppl; 1993; 33():183-213. PubMed ID: 8512739
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cytogenetic studies in hematologic disease].
    Sánchez Avalos JC
    Medicina (B Aires); 1981; 41(3):385-9. PubMed ID: 7321860
    [No Abstract]   [Full Text] [Related]  

  • 18. [Chromosome aberrations and malignant lymphomas].
    Fonatsch C; Gradl G
    Onkologie; 1987 Aug; 10(4):206-16. PubMed ID: 3313144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alzheimer's disease and senile dementia: genetic relationships to Down's syndrome and hematologic cancer.
    Heston LL
    Res Publ Assoc Res Nerv Ment Dis; 1979; 57():167-76. PubMed ID: 154163
    [No Abstract]   [Full Text] [Related]  

  • 20. [Cytogenetics of malignant hemopathies: update].
    Lai JL; Genevière F; Zandecki M
    Bull Cancer; 1999 Jan; 86(1):23-8. PubMed ID: 10029700
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.